Ara
Toplam kayıt 9, listelenen: 1-9
Prognostic Significance of Adjuvant Chemotherapy Induced Amenorrhea in Luminal A and B Subtypes
(AVES, 2018)
Objective: In this retrospective study, chemotherapy induced amenorrhea in patients with early stage breast cancer and its effects on survival were investigated. Materials and Methods: Two hundred fifty-two patients received ...
The Effect of Systemic Chemotherapy on Ovarian Function: A Prospective Clinical Trial
(Aves, 2020)
Objective: Premenopausal women with breast cancer arc at risk of developing ovarian failure after chemotherapy. the aim of this study was to investigate the negative effects of systemic chemotherapy on ovarian function in ...
Is administration of trastuzumab an independent risk factor for developing osteonecrosis of the jaw among metastatic breast cancer patients under zoledronic acid treatment?
(Lippincott, Williams & Wilkins, 2015)
One of the most important adverse effects of zoledronic acid (ZA) is osteonecrosis of the jaw (ONJ). In previous literature, several risk factors have been identified in the development of ONJ. In this study, we aimed to ...
The prognostic impact of molecular subtypes and very young age on breast conserving surgery in early stage breast cancer
(Cureus, Inc., 2016)
Background: Premenopausal breast cancer with a triple-negative phenotype (TNBC) has been associated with inferior locoregional recurrence free survival (LRFS) and overall survival (OS) after breast conserving surgery (BCS). ...
Vitamin D levels in patients with breast cancer: importance of dressing style.
(Asian Pacific Education Press Ltd., 2014)
Background: Vitamin D deficiency is a potentially modifiable risk factor that may be targeted for breast cancer (BC) prevention. It may also be related to prognosis after diagnosis and treatment. The aim of our study was ...
Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients
(SPANDIDOS PUBL LTD, 2015)
The aim of the present study was to identify the optimal Ki-67 cut-off value in breast cancer (BC) patients, and investigate the association of Ki-67 expression levels with other prognostic factors. Firstly, a retrospective ...
True local recurrences after breast conserving surgery have poor prognosis in patients with early breast cancer.
(Cureus Inc., 2016)
Background: This study was aimed at investigating clinical and histopathologic features of ipsilateral breast tumor recurrences (IBTR) and their effects on survival after breast conservation therapy.
Methods: 1,400 patients ...
Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study
(Mdpi, 2023)
Estradiol (E2), a follicle-stimulating hormone (FSH), AMH, and inhibin B levels, along with AFC and MOV, are used to determine ovarian reserve in pre-menopausal women. Studies have shown that AMH levels are more sensitive ...
MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification
(Dove Medical Press Ltd, 2023)
Background: The minichromosome maintenance protein-2 (MCM-2) is a more sensitive proliferation marker than Ki-67. This study aimed to evaluate the relationship between MCM-2 and Oncotype DX recurrence score (ODX-RS) and ...